|
⚲
|
| Keyboard |
| Marc Penn | |
|---|---|
| Firm | |
| Address | 1375 W Fulton Street Ste 650 Chicago, IL 60607 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Inomagen Therapeutics Inc | 021-549400 | Director | 0.1 M of 3.8 M |
||
| Foment Bio Inc | 021-541691 | Director | 0.5 M of 1.0 M |
||
| Inomagen Therapeutics Inc | 021-510456 | Director | 0.2 M of 6.6 M |
||
| Diasome Pharmaceuticals Inc | 021-485696 | Director | 9.0 M of 15.0 M |
||
| Diasome Pharmaceuticals Inc | 021-458372 | Director | 16.7 M of 19.1 M |
||
| Diasome Pharmaceuticals Inc | 021-384219 | Director | 1.5 M of 5.0 M |
||
| Diasome Pharmaceuticals Inc | 021-364119 | Director | 2.9 M of 2.9 M |
||
| Keystone Bio Inc | 021-338327 | Director | 5.0 M of 5.0 M |
||
| Diasome Pharmaceuticals Inc | 021-324483 | Director | 12.1 M of 18.6 M |
||
| Juventas Therapeutics Inc | 021-240201 | Executive Officer | 7.4 M of 7.4 M |
||
| Juventas Therapeutics Inc | 021-206673 | Director | 5.0 M of 5.0 M |
||
| Juventas Therapeutics Inc | 021-123642 | Director | 22.1 M of 22.1 M |
||